Overall market sentiment has been high on G1 Therapeutics Inc (GTHX) stock lately. GTHX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
G1 Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on GTHX!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With GTHX Stock Today?
G1 Therapeutics Inc (GTHX) stock is trading at $1.70 as of 12:40 PM on Tuesday, Oct 31, an increase of $0.12, or 7.28% from the previous closing price of $1.58. The stock has traded between $1.55 and $1.72 so far today. Volume today is 437,763 compared to average volume of 572,617.
To see InvestorsObserver's Sentiment Score for G1 Therapeutics Inc click here.
More About G1 Therapeutics Inc
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast cancer, and designs them to combine - and enhance - the anti-tumor activity of current therapies.
Click Here to get the full Stock Report for G1 Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
